What Is Prolotherapy, and When Is It the Right Choice?

Prolotherapy is one of the oldest regenerative injection treatments — and still one of the most useful for loose, painful joints and chronic ligament and tendon problems. Here is how it works, what it treats, and how we decide between prolotherapy and PRP.

What Is Prolotherapy?

Prolotherapy — short for “proliferation therapy” — is a non-surgical injection treatment for chronic musculoskeletal pain. A small amount of an irritant solution, most commonly dextrose (a medical-grade sugar), is injected at the precise points where ligaments and tendons attach to bone. That brief, controlled irritation prompts the body to mount a localized healing response, drawing in the cells and growth factors that repair and tighten connective tissue.

The idea is straightforward: many chronic pains come from connective tissue that has become stretched, weakened, or incompletely healed. Rather than masking that pain, prolotherapy aims to stimulate the body to reinforce the structure itself. It is one of the oldest regenerative injection techniques, with a track record stretching back decades.

How It Works

Ligaments and tendons have a notoriously poor blood supply, which is why injuries to them can linger for months or years and why they often heal incompletely on their own. When a joint is supported by lax or damaged ligaments, it can move slightly more than it should. That subtle instability irritates surrounding nerves and muscles, producing pain that is hard to pin down and tends to come back.

By introducing a mild irritant exactly where the tissue attaches to bone, prolotherapy triggers a fresh, organized round of the body’s natural repair process. Over a series of sessions, the goal is stronger, tighter connective tissue, a more stable joint, and less pain. Treatment is typically delivered as a course of several visits spaced a few weeks apart, often guided by ultrasound for accurate placement.

What Prolotherapy Treats

Prolotherapy is most useful for pain driven by ligament or tendon laxity and chronic connective-tissue injuries, including:

• Chronic low back and sacroiliac (SI) joint pain
• Joint instability and ligament laxity, including the knee and ankle
• Tendon problems such as tennis elbow and other overuse tendinopathies
• Mild to moderate osteoarthritis of the knee and other joints
• Neck pain related to ligament laxity

It is not the right tool for every problem. Acute fractures, complete tendon ruptures, active infections, and pain that is primarily inflammatory or nerve-compressive in nature usually call for a different approach — which is exactly why an accurate diagnosis comes before any injection.

Prolotherapy vs. PRP: How We Decide

Patients often ask whether they need prolotherapy or platelet-rich plasma (PRP). Both are regenerative injections that work by stimulating the body’s own repair response, and they share the same underlying philosophy. The difference is in what is injected and how strong a healing signal it sends.

• Prolotherapy uses a dextrose-based solution to provoke a healing response. It is well suited to ligament laxity, joint instability, and broader areas that need reinforcement, and it is generally the more economical option.
• PRP uses a concentrated portion of your own blood, delivering a high dose of growth factors directly to a specific injured tendon, joint, or nerve root. It tends to be chosen for more focal, higher-grade tissue damage where a stronger biologic signal is warranted.

In practice the choice depends on the diagnosis, the severity and location of the problem, your goals, and practical factors like cost. The two are not mutually exclusive — some patients do best with prolotherapy for a broad area of instability, others with targeted PRP, and some with a plan that uses each where it fits. This is a clinical decision, not a one-size-fits-all formula.

When Prolotherapy Is the Right Choice

Prolotherapy tends to be a strong fit when pain is coming from lax or weakened ligaments and tendons, when a joint feels subtly unstable, when conservative care like physical therapy has helped but not resolved the problem, and when you want a non-surgical option that addresses the underlying structure rather than just calming symptoms. It can be a sensible first regenerative step for the right connective-tissue problem.

As with any regenerative treatment, results vary from person to person and depend on the diagnosis, the tissue involved, and how well the treatment is matched to the problem. It is best thought of as part of a thoughtful plan, not a guaranteed cure.

Conclusion

Prolotherapy remains a valuable, evidence-informed option for chronic ligament, tendon, and joint pain — especially where instability and incomplete healing are driving the problem. Whether prolotherapy, PRP, or a combination makes the most sense for you comes down to an accurate diagnosis and a treatment matched to it. The best next step is a thorough evaluation to confirm what is causing your pain and which approach fits your goals.